Kimberly practices in product liability complex litigation, with a focus on life sciences and health matters. She has extensive experience in managing litigation spanning multiple jurisdictions, in consolidated and multidistrict proceedings and in class actions.

Kimberly’s product liability work spans pharmaceuticals, medical devices and other mechanical devices. Her knowledge of science, including an undergraduate degree in natural sciences from Johns Hopkins University as well as master’s degrees in biochemistry and sociology, allows her to research and incorporate the science underlying claims of injury from pharmaceutical and medical device use. Pharmaceutical product liability cases she has defended include DES, Provera, anxiolytics, sleeping medication, Depo-Provera contraceptive injection, antidepressants, antiemetics, antidiabetic medications, phenylpropanolamine (PPA) and hormone replacement therapy for men and women. She has also represented medical device manufacturers of products such as the Dalkon Shield, breast implants and implantable orthopedic devices. Her clients have included Upjohn, Pharmacia, Pfizer, Bristol-Myer Squibb, GlaxoSmithKline and AbbVie.

As national counsel for Pfizer in the Depo-Provera Contraceptive Injection bone mineral density litigation, Kimberly led her team to five summary judgment wins in federal courts around the country, including a dismissal of a multi-plaintiff case in the Southern District of Mississippi.

Kimberly is also a registered patent attorney, which also gives her an edge in much of her product liability litigation work. In addition to her aforementioned product liability cases, Kimberly has defended manufacturers of power tools, radio-controlled cars and smoke detectors. Her litigation experience extends to the appellate courts of both state and federal jurisdictions. 

In addition to her science degrees and patent registration, Kimberly recognizes the importance of the emerging role of genetics in pharmaceutical litigation and was recently awarded an advanced degree in genomics and individualized medicine from Johns Hopkins.

Representative Matters

Oliver v. Pharmacia & Upjohn Co., No. 06-5737, 2008 WL 4691626 (E.D. La. Oct 22, 2008).

Counsels Colville v. Pharmacia & Upjohn Co., 565 F. Supp. 2d 1314 (N.D. Fla. 2008).

Montagnon v. Pfizer, Inc., 584 F. Supp. 2d 459 (D. Conn. 2008).

Lorenzi v. Pfizer, Inc., 519 F. Supp. 2d 742 (N.D. Ohio 2007).

Taylor v. Pharmacia-Upjohn Co., No. 4:03CV148LN, 2005 WL 3502052 (S.D. Miss. Dec 19, 2005). 



Personalized Medicine | 60 Seconds of Legal Science